ZTS - Zoetis Inc
161.92
| Index: | S&P 500 | P/E: | 29.08 | EPS (ttm): | 5.57 | Insider Own: | 0.10% | Shs Outstand: | 446.04M | Perf Week: | 2.44% |
| Market Cap: | 72.09B | Forward P/E: | 23.64 | EPS next Y: | 6.85 | Insider Trans: | -1.27% | Shs Float: | 444.76M | Perf Month: | 10.15% |
| Income(ttm): | 2.52B | PEG: | 3.44 | EPS next Q: | 1.62 | Inst Own: | 96.43% | Short Float: | 2.10% | Perf Quarter: | -5.81% |
| Revenue(ttm): | 9.29B | P/S: | 7.76 | EPS this Y: | 4.87% | Inst Trans: | -1.11% | Short Ratio: | 2.86 | Perf Half Y: | -4.96% |
| Book/sh: | 10.44 | P/B: | 15.52 | EPS next Y: | 10.31% | ROA: | 17.70% | Short Interest: | 9.33M | Perf Year: | -1.82% |
| Cash/sh: | 3.87 | P/C: | 41.89 | EPS next 5Y: | 8.46% | ROE: | 51.85% | 52W Range: | 139.70 - 200.33 | Perf YTD: | -0.62% |
| Dividend Est.: | 1.99 (1.23%) | P/FCF: | 31.60 | EPS past 5Y: | 11.91% | ROI: | 25.04% | 52W High: | -19.17% | Beta: | 0.93 |
| Dividend TTM: | 1.86 (1.15%) | Quick Ratio: | 1.04 | Sales past 5Y: | 8.22% | Gross Margin: | 69.48% | 52W Low: | 15.91% | ATR (14): | 5.11 |
| Dividend Ex-Date: | Apr 21, 2025 | Current Ratio: | 1.74 | EPS Y/Y TTM: | 7.23% | Oper. Margin: | 37.01% | RSI (14): | 57.86 | Volatility: | 3.87% 3.05% |
| Employees: | 13800 | Debt/Eq: | 1.45 | Sales Y/Y TTM: | 6.32% | Profit Margin: | 27.12% | Recom: | 1.43 | Target Price: | 200.29 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.16 | EPS Q/Q: | 7.88% | Payout: | 32.86% | Rel Volume: | 1.05 | Prev Close: | 159.27 |
| Sales Surprise: | 1.37% | EPS Surprise: | 5.00% | Sales Q/Q: | 1.37% | Earnings: | May 06 BMO | Avg Volume: | 3.26M | Price: | 161.92 |
| SMA20: | 5.34% | SMA50: | 2.24% | SMA200: | -6.55% | Undervalued: 23.7% | Volume: | 3,418,923 | Change: | 1.66% | |
Graham Classic formula value: 127.14
(P/E=8 * 1g) Min value: 82.33
(current P/E * 2g) Max value: 230.08
Average value: 146.52
About Zoetis Inc
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.